[RGLS] YoY Quarter Result on 30-Jun-2013 [#Q2]

Stock
[RGLS] Regulus Therapeutics Inc.
Announcement Date
13-Aug-2013
Financial Year
2013
Quarter
30-Jun-2013 [#Q2]
Profit Trend
QoQ- -1.65%
YoY- -182.72%
Quarter Report
RGLS's Result
RGLS's Financial Summary
View:
Show?
Quarter Result
30/06/18 30/06/17 30/06/16 30/06/15 30/06/14 30/06/13 30/06/12 CAGR
Revenue 18 18 483 3,834 736 4,759 3,309 -58.04%
PBT -13,847 -21,736 -21,098 -21,037 -11,973 -7,338 -2,621 31.95%
Tax 118 -128 -8 -2 10 10 -22 -
NP -13,847 -21,608 -21,090 -21,035 -11,973 -7,348 -2,599 32.14%
Tax Rate - - - - - - - -
Total Cost 13,865 21,626 21,573 24,869 12,709 12,107 5,908 15.27%
Ratio Analysis
30/06/18 30/06/17 30/06/16 30/06/15 30/06/14 30/06/13 30/06/12 CAGR
NP Margin -76,927.78 -120,044.44 -4,366.46 -548.64 -1,626.77 -154.40 -78.54 214.97%
Per Share
30/06/18 30/06/17 30/06/16 30/06/15 30/06/14 30/06/13 30/06/12 CAGR
EPS -15.93 -48.76 -47.95 -49.42 -33.13 -24.50 -1,293.03 -51.92%
EPS Diluted -15.93 -48.76 -47.95 -49.42 -32.07 -24.50 -1,293.03 -51.92%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.